Physician Assistant Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Emily Knowlton

Physician Assistant Fairfield, CT Physician Assistant

NPI 1023664125 CMS profile 7193144

2000 Post Rd Ste 202, Fairfield, CT 06824

Open in the dashboard

General payments

$9,660

544 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Emily Knowlton of Fairfield, CT is reported in the CMS Open Payments database as having received $9,660 across 544 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $1,653 86
2022 General $3,948 216
2021 General $4,043 241
2019 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Knowlton
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Emily Knowlton were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Emily Knowlton Physician Assistant median Middle half National median
2019 $16 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $4,043 $132 $37–$438 $132
2022 $3,948 $155 $48–$522 $149
2023 $1,653 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $1,665 108 payments
  2. Bausch Health US, LLC $719 39 payments
  3. GlaxoSmithKline, LLC. $673 37 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $527 34 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $505 28 payments
  6. AstraZeneca Pharmaceuticals LP $444 25 payments
  7. Sunovion Pharmaceuticals Inc. $432 28 payments
  8. Avanir Pharmaceuticals, Inc. $399 15 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $314 20 payments
  10. Ironwood Pharmaceuticals, Inc $292 18 payments
  11. Other $3,691 192 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $9,561 543 payments
  2. Education $99 1 payment
Products named General payments · program years 2019–2023
  1. VRAYLAR $775 51 payments
  2. APLENZIN $658 36 payments
  3. TRELEGY ELLIPTA $605 33 payments
  4. JARDIANCE $406 19 payments
  5. NUEDEXTA $399 15 payments
  6. XIFAXAN $384 22 payments
  7. FARXIGA $361 20 payments
  8. UBRELVY $335 23 payments
  9. QULIPTA $328 19 payments
  10. TRINTELLIX $299 18 payments
  11. Other $7,119 396 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

544 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record